PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results
Records returned : 26.
-
Asfotase alfa - Metabolic disorders
Brand names include : Strensiq
-
Carnitine - Metabolic disorders
Brand names include : Carnitor
-
Chenodeoxycholic acid - Metabolic disorders
-
Cholic acid - Metabolic disorders
-
Cipaglucosidase alfa - Metabolic disorders
-
Eladocagene exuparvovec - Metabolic disorders
Brand names include : Upstaza
-
Elosulfase alfa - Metabolic disorders
Brand names include : Vimizim
-
Emricasan - Metabolic disorders
-
Galsulfase - Metabolic disorders
-
Glycerol phenylbutyrate - Metabolic disorders
-
Human alpha mannosidase recombinant - Metabolic disorders
-
Human heterologous liver cells - Metabolic disorders
-
Idursulfase - Metabolic disorders
Brand names include : Elaprase
-
Laronidase - Metabolic disorders
Brand names include : Aldurazyme
-
Mercaptamine - Metabolic disorders
Brand names include : Cystagon, Procysbi
-
Migalastat - Metabolic disorders
Brand names include : Galafold
-
Nitisinone - Metabolic disorders
Brand names include : Orfadin
-
Reveglucosidase alfa - Metabolic disorders
-
Sebelipase alfa - Metabolic disorders
Brand names include : Kanuma
-
Sialic acid - Metabolic disorders
-
Taliglucerase alfa - Metabolic disorders
-
Tetrahydrobiopterin - Metabolic disorders
-
Trientine - Metabolic disorders
Brand names include : Cuprior, Cufence
-
Velaglucerase alfa - Metabolic disorders
-
Velcalcetide - Metabolic disorders
-
Chenodeoxycholic acid - Primary biliary cholangitis
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients